Single-center, prospective, and observational study on the management and treatment of impetigo in a pediatric population

CONCLUSIONS: Topical ozenoxacin has strong efficacy in treating impetigo in pediatric patients. Ozenoxacin's clinical and microbiological rapid onset of response led to consider this antibiotic a novel efficacy option for the treatment of impetigo.PMID:37843341 | DOI:10.26355/eurrev_202310_33955

Source: Pharmacological Reviews - October 16, 2023 Category: Drugs & Pharmacology Authors: A Gatto L Capossela S Ferretti L Di Sarno A Oliveti D Talamonti A Curatola A Chiaretti B Fiori Source Type: research